drugset / Trial / NCT01108731
The Effect of Milnacipran in Patients With Fibromyalgia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Use of the drug Milnacipran will reduce ventricular lactate levels and processing time for completing complex tasks relative to placebo.
Timeline
- Start
- 2010-03
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Milnacipran | Other / unclassified | 50 mg | — |